600521.SHG Zhejiang Huahai Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
17.87 CNY
Close of Nov 5, 2026
13.73 19.14
Market cap
CNY 26.8B
P/E
28.4x
P/B
2.46x
ROE
14.0%
Dividend yield
2.04%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600521.SHG undervalued?

Graham number
Price17.87
Graham value10.15
Premium76.1%

600521.SHG trades 76.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zhejiang Huahai Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Zhejiang Huahai Pharmaceutical Co Ltd yet.

Zhejiang Huahai Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zhejiang Huahai Pharmaceutical Co Ltd

Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production, and sales of generic drugs, biologics, drugs, and specialty active pharmaceutical ingredients in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals. In …

Full company profile